Varicella Zoster Infection Treatment Market: Purchases from Drug Stores to Rise as Demand for Topicals Take a Surge: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)
- REP-GB-6466
- 2018-03-21
- Category: Healthcare, Pharmaceuticals and Medical devices
- 276 Pages
- Format:
Varicella zoster spreads easily from people with chickenpox to others who never had the disease or been vaccinated. It can be transmitted by respiratory droplets, from skin lesions, by direct contact or possibly by aerosolisation of the virus from skin lesions. Chickenpox can spread from people with shingles to others who never had chickenpox or received the chickenpox vaccine. According to a study of the Centers of Disease Control and Prevention, transmission of varicella is high among household members. About 90% of varicella cases are susceptible to close contact with people suffering from varicella. In schools and day care centres the transmission rate among susceptible children tend to be lower than 30%–50%. Varicella occurs worldwide with ongoing endemic transmission in areas where the population is sufficiently large to support such transmission.
Purchase of drugs through hospital pharmacies to increase in the coming years
Pregnant women, kids, and the geriatric population have the highest risks of developing a varicella zoster infection. As a result, if any person or kid is infected, they are either admitted or prescribed specific medicines or drugs for the treatment of the varicella zoster infection. Some of the medicines are only sold by hospital pharmacies as these medicines can only be bought if prescribed by a doctor or medical practitioner. Stringent regulations are also another reason for an increasing number of purchases from hospital pharmacies. The FDA regulatory approval process for drugs is strict. Therefore, these challenges in the regulatory environment are prompting investors in the industry to shift their investments overseas, which may act as a restraint for the growth of the varicella zoster infection treatment market. Most of the companies are facing difficulties in bringing herpes zoster drugs and vaccines to the market without the necessary FDA approvals. As a result, the approved drugs can only be bought if prescribed by a qualified healthcare professional and from specific hospital pharmacies.
Retail pharmacies to get a boost with increasing healthcare expenditure and an advanced healthcare model
According to the IMF, global healthcare expenditure is expected to increase by over 6% yearly, based on the current GDP forecast. The rising geriatric population in developed countries and growing affluence in emerging markets are likely to boost healthcare expenditure. In the U.S., prescription drugs comprise 10% of the national health expenditure and this is expected to increase in the coming years. Besides, high spending on prescription drugs is attributed to the increased spending on new medicines, increased spending on generics, price rise of existing branded drugs, and fewer expensive blockbuster drugs going off-patent.
The governments and regulatory bodies of several countries are adopting various cost containment measures to reduce the healthcare burden, especially in developed economies. This change from a volume- to a value-based system is driven by various measures taken by the governments, healthcare providers, payers and pharmaceutical companies, which include outcome-based pricing, profit and risk sharing, price control and competitive tendering. The value-based healthcare model is expected to help achieve supreme value for money spent on healthcare and thus improve the outcomes through integrated care pathways. Nevertheless, at the same time it would levy pricing pressure on biopharmaceutical and medtech companies, which may impact R&D investment for innovative medical treatment technologies. As a result of all these factors, the demand for bulk medicines is increasing and as retail pharmacies are the best place to obtain medicines in bulk, these pharmacies are getting a good push in the global market.
Global Healthcare Sector Outlook
Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.
A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, blockchain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.
Parent Indicators Healthcare
-
Current expenditure on health, % of gross domestic product
-
Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs)
-
Annual growth rate of current expenditure on health, per capita, in real terms
-
Out-of-pocket expenditure, % of current expenditure on health
-
Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs)
-
Physicians, Density per 1000 population (head counts)
-
Nurses, Density per 1000 population (head counts)
-
Total hospital beds, per 1000 population
-
Curative (acute) care beds, per 1000 population
-
Medical technology, Magnetic Resonance Imaging units, total, per million population
-
Medical technology, Computed Tomography scanners, total, per million population
Research Methodology
FMI utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, to obtain precise market estimations and insights on Molecule and Drug Classes, API Formulations and preferred modes of administration. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.
Secondary research is used at the initial phase to identify the age specific disease epidemiology, diagnosis rate and treatment pattern, as per disease indications. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.
Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, nursing managers, clinical specialists who provide valuable insights on trends and clinical application of the drugs, key treatment patterns, adoption rate, and compliance rate.
Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.
On the other hand, we also analyse various companies annual reports, investor presentations, SEC filings, 10k reports and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at Tier level based on their revenues, product portfolio and presence.
Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.
Standard Report Structure
-
Executive Summary
-
Market Definition
-
Macro-economic analysis
-
Parent Market Analysis
-
Market Overview
-
Forecast Factors
-
Segmental Analysis and Forecast
-
Regional Analysis
-
Competition Analysis
Market Taxonomy
|
Drug Type |
Route of Administration |
Distribution Channel |
Region |
|---|---|---|---|
|
|
|
|
Report Methodology
The analyst has used the epidemiology model and has calculated the incidence rate among old age people, pregnant women, and children to arrive at certain assumptions about this market.
Varicella Zoster Infection Treatment Market Reports - Table of Contents
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. Wheel of Fortune
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Varicella Zoster Infection Treatment Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Restraints
5. Global Economic Outlook
5.1. Disease Outlook
6. Key Inclusions
6.1. Key Manufacture List
6.2. Prescription Pattern
7. North America Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025
7.1. Introduction
7.2. Regional Market Trends
7.3. Regional Scenario
7.4. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
7.4.1. U.S.
7.4.2. Canada
7.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
7.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
7.6.1. Acyclovir
7.6.2. Valacyclovir
7.6.3. Famciclovir
7.7. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
7.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016
7.8.1. Oral
7.8.2. Topical
7.8.3. Injectable
7.9. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025
7.10. Historical Market Size (US$ Mn) and Volume Trend Analysis By Distribution Channel, 2012–2016
7.10.1. Hospital Pharmacies
7.10.2. Retail Pharmacies
7.10.3. Online Pharmacies
7.10.4. Drug Stores
7.11. Market Size (US$ Mn) and Volume Forecast By Distribution Channel, 2017–2025
7.12. Market Attractiveness Analysis
7.12.1. By Country
7.12.2. By Drug Type
7.12.3. By Route of Administration
7.12.4. By Distribution Channel
7.13. Key Market Participants – Intensity Mapping
8. Latin America Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025
8.1. Introduction
8.2. Regional Market Trends
8.3. Regional Scenario
8.4. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
8.4.1. Brazil
8.4.2. Mexico
8.4.3. Rest of Latin America
8.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
8.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
8.6.1. Acyclovir
8.6.2. Valacyclovir
8.6.3. Famciclovir
8.7. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
8.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016
8.8.1. Oral
8.8.2. Topical
8.8.3. Injectable
8.9. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025
8.10. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016
8.10.1. Hospital Pharmacies
8.10.2. Retail Pharmacies
8.10.3. Online Pharmacies
8.10.4. Drug Stores
8.11. Market Size (US$ Mn Forecast By Distribution Channel, 2017–2025
8.12. Market Attractiveness Analysis
8.12.1. By Country
8.12.2. By Drug Type
8.12.3. By Route of Administration
8.12.4. By Distribution Channel
8.13. Key Market Participants – Intensity Mapping
9. Western Europe Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025
9.1. Introduction
9.2. Regional Market Trends
9.3. Regional Scenario
9.4. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
9.4.1. Germany
9.4.2. U.K.
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Rest of Western Europe
9.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
9.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
9.6.1. Acyclovir
9.6.2. Valacyclovir
9.6.3. Famciclovir
9.7. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
9.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016
9.8.1. Oral
9.8.2. Topical
9.8.3. Injectable
9.9. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025
9.10. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016
9.10.1. Hospital Pharmacies
9.10.2. Retail Pharmacies
9.10.3. Online Pharmacies
9.10.4. Drug Stores
9.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025
9.12. Market Attractiveness Analysis
9.12.1. By Country
9.12.2. By Drug Type
9.12.3. By Route of Administration
9.12.4. By Distribution Channel
9.13. Key Market Participants – Intensity Mapping
10. Eastern Europe Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025
10.1. Introduction
10.2. Regional Market Trends
10.3. Regional Scenario
10.4. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
10.4.1. Russia
10.4.2. Poland
10.4.3. Rest of Eastern
10.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
10.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
10.6.1. Acyclovir
10.6.2. Valacyclovir
10.6.3. Famciclovir
10.7. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
10.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016
10.8.1. Oral
10.8.2. Topical
10.8.3. Injectable
10.9. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025
10.10.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016
10.10.1. Hospital Pharmacies
10.10.2. Retail Pharmacies
10.10.3. Online Pharmacies
10.10.4. Drug Stores
10.11.Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025
10.12.Market Attractiveness Analysis
10.12.1. By Country
10.12.2. By Drug Type
10.12.3. By Route of Administration
10.12.4. By Distribution Channel
10.13.Key Market Participants – Intensity Mapping
11. Asia Pacific Excluding China & Japan Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025
11.1. Introduction
11.2. Regional Scenario
11.3. Regional Market Trends
11.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
11.4.1. India
11.4.2. Australia and New Zealand
11.4.3. ASEAN
11.4.4. Rest of APECJ
11.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
11.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
11.6.1. Acyclovir
11.6.2. Valacyclovir
11.6.3. Famciclovir
11.7. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
11.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016
11.8.1. Oral
11.8.2. Topical
11.8.3. Injectable
11.9. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025
11.10.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016
11.10.1. Hospital Pharmacies
11.10.2. Retail Pharmacies
11.10.3. Online Pharmacies
11.10.4. Drug Stores
11.11.Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025
11.12.Market Attractiveness Analysis
11.12.1. By Country
11.12.2. By Drug Type
11.12.3. By Route of Administration
11.12.4. By Distribution Channel
11.13.Key Market Participants – Intensity Mapping
12. China Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025
12.1. Introduction
12.2. Key Regulations
12.3. Regional Market Trends
12.4. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
12.4.1. Acyclovir
12.4.2. Valacyclovir
12.4.3. Famciclovir
12.5. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
12.6. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016
12.6.1. Oral
12.6.2. Topical
12.6.3. Injectable
12.7. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025
12.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016
12.8.1. Hospital Pharmacies
12.8.2. Retail Pharmacies
12.8.3. Online Pharmacies
12.8.4. Drug Stores
12.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025
12.10.Market Attractiveness Analysis
12.10.1. By Country
12.10.2. By Drug Type
12.10.3. By Route of Administration
12.10.4. By Distribution Channel
12.11.Key Market Participants – Intensity Mapping
13. Japan Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025
13.1. Introduction
13.2. Key Regulations
13.3. Regional Market Trends
13.4. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
13.4.1. Acyclovir
13.4.2. Valacyclovir
13.4.3. Famciclovir
13.5. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
13.6. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016
13.6.1. Oral
13.6.2. Topical
13.6.3. Injectable
13.7. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025
13.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016
13.8.1. Hospital Pharmacies
13.8.2. Retail Pharmacies
13.8.3. Online Pharmacies
13.8.4. Drug Stores
13.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025
13.10.Market Attractiveness Analysis
13.10.1. By Country
13.10.2. By Drug Type
13.10.3. By Route of Administration
13.10.4. By Distribution Channel
13.11.Key Market Participants – Intensity Mapping
14. Middle East & Africa Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025
14.1. Introduction
14.2. Regional Scenario
14.3. Regional Market Trends
14.4. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016
14.4.1. GCC Countries
14.4.2. North Africa
14.4.3. South Africa
14.4.4. Rest of MEA
14.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
14.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
14.6.1. Acyclovir
14.6.2. Valacyclovir
14.6.3. Famciclovir
14.7. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
14.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016
14.8.1. Oral
14.8.2. Topical
14.8.3. Injectable
14.9. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025
14.10.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016
14.10.1. Hospital Pharmacies
14.10.2. Retail Pharmacies
14.10.3. Online Pharmacies
14.10.4. Drug Stores
14.11.Market Size (US$ Mn) By Distribution Channel, 2017–2025
14.12.Market Attractiveness Analysis
14.12.1. By Country
14.12.2. By Drug Type
14.12.3. By Route of Administration
14.12.4. By Distribution Channel
14.13.Key Market Participants – Intensity Mapping
15. Forecast Factors: Relevance and Impact
16. Forecast Assumptions
17. Competition Analysis
17.1. Competition Dashboard
17.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
17.2.1. Teva Pharmaceutical Industries Ltd.
17.2.2. Abbott Laboratories
17.2.3. Sun Pharmaceuticals Industries Ltd.
17.2.4. Mylan N.V.
17.2.5. Pfizer Inc.
17.2.6. GlaxoSmithKline plc.
17.2.7. Dr. Reddy’s Laboratories, ltd.
17.2.8. Novartis AG
17.2.9. Valeant Pharmaceuticals International Inc.
18. Global Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By Region
18.1. Introduction/Key Findings
18.2. Historical Market Size (US$ Mn) Analysis By Region, 2012–2016
18.3. Market Size (US$ Mn) Forecast By Region, 2017–2025
18.3.1. North America
18.3.2. Latin America
18.3.3. Western Europe
18.3.4. Eastern Europe
18.3.5. Asia Pacific Excluding China & Japan
18.3.6. China
18.3.7. Japan
18.3.8. Middle East & Africa
18.4. Market Attractiveness Analysis By Region
19. Global Varicella Zoster Infection Treatment Analysis 2012–2016 and Forecast 2017–2025, By Drug Type
19.1. Introduction/Key Findings
19.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012–2016
19.2.1. Acyclovir
19.2.2. Valacyclovir
19.2.3. Famciclovir
19.3. Market Size (US$ Mn) Forecast By Drug Type, 2017–2025
19.4. Market Attractiveness Analysis By Drug Type
20. Global Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By Route of Administration
20.1. Introduction/Key Findings
20.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012–2016
20.2.1. Oral
20.2.2. Topical
20.2.3. Injectable
20.3. Market Size (US$ Mn) Forecast By Route of Administration, 2017–2025
20.4. Market Attractiveness Analysis By Route of Administration
21. Global Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025, By Distribution Channel
21.1. Introduction/Key Findings
21.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012–2016
21.2.1. Hospital Pharmacies
21.2.2. Retail Pharmacies
21.2.3. Online Pharmacies
21.2.4. Drug Stores
21.3. Market Size (US$ Mn) By Distribution Channel, 2017–2025
21.4. Market Attractiveness Analysis By Distribution Channel
22. Global Varicella Zoster Infection Treatment Market Analysis 2012–2016 and Forecast 2017–2025
22.1. Market Value Share Analysis By All Segment
22.2. Y-o-Y Growth Analysis By All Segment
22.3. Absolute $ Opportunity
23. Assumptions and Acronyms Used
24. Research Methodology
Varicella Zoster Infection Treatment Market Reports - List of Tables
Table 01: North America Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 02: North America Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type
Table 03: North America Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration
Table 04: North America Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel
Table 05: North America Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)
Table 06: Latin America Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 07: Latin America Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type
Table 08: Latin America Varicella Zoster Infection Treatment Market size (US$ Mn)Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration
Table 09: Latin America Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel
Table 10: Latin America Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)
Table 11: Western Europe Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 12: Western Europe Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type
Table 13: Western Europe Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration
Table 14: Western Europe Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel
Table 15: Western Europe Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)
Table 16: Eastern Europe Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 17: Eastern Europe Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type
Table 18: Eastern Europe Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration
Table 19: Eastern Europe Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel
Table 20: Eastern Europe Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)
Table 21: APECJ Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 22: APECJ Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type
Table 23: APECJ Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration
Table 24: APECJ Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel
Table 25: APECJ Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)
Table 26: China Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type
Table 27: China Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration
Table 28: China Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel
Table 29: China Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)
Table 30: Japan Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type
Table 31: Japan Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration
Table 32: Japan Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel
Table 33: Japan Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)
Table 34: MEA Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 35: MEA Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type
Table 36: MEA Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration
Table 37: MEA Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel
Table 38: MEA Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)
Table 39: Global Varicella Zoster Infection Treatment Market Size (US$ Mn) Forecast By Region, 2012–2017
Table 40: Global Varicella Zoster Infection Treatment Market size Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Drug Type
Table 41: Global Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Route of Administration
Table 42: Global Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Distribution Channel
Varicella Zoster Infection Treatment Market Reports - List of Figures
Figure 01: Global Varicella Zoster Infection Treatment Market Value Share By Drug Type 2017 (A)
Figure 02: Global Varicella Zoster Infection Treatment Market Value Share By Route of Administration 2017 (A)
Figure 03: Global Varicella Zoster Infection Treatment Market Value Share By Distribution Channel 2017 (A)
Figure 04: Varicella Zoster Infection Treatment Market Split By Drug Type (2017)
Figure 05: Varicella Zoster Infection Treatment Market Split By Route of Administration (2017)
Figure 06: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2017)
Figure 07: Varicella Zoster Infection Treatment Market Split By Country (2017)
Figure 8: North America Varicella Zoster Infection Treatment Market Size Analysis, 2012–2016
Figure 9: North America Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2017–2027
Figure 10: U.S. Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 11: U.S. Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 12: Canada Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 13: Canada Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 14: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 15: Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 16: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 17: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 18: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 19: Famciclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 20: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 21: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 22: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 23: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 24:Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 25: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 26: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 27: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 28: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 29: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 30: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 31: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 32: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 33: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 34: North America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2017–2027
Figure 35: North America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027
Figure 36: North America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2027
Figure 37: North America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Country, 2017–2027
Figure 38: Varicella Zoster Infection Treatment Market Split By Drug Type (2017)
Figure 39: Varicella Zoster Infection Treatment Market Split By Route of Administration (2017)
Figure 40: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2017)
Figure 41: Varicella Zoster Infection Treatment Market Split By Country (2017)
Figure 42: Latin America Varicella Zoster Infection Treatment Market Size Analysis, 2012–2016
Figure 43: Latin America Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2017–2027
Figure 44: Brazil Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 45: Brazil Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 46: Mexico Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 47: Mexico Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 48: Rest of Latin America Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2017
Figure 49: Rest of Latin America Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 50: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 51: Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 52: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 53: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 54: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 55: Famciclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 56: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 57: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 58: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 59: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 60: Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 61: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 62: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 63: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 64: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 65: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 66: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 67: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 68: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 69: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 70: Latin America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2017–2027
Figure 71: Latin America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route ofAdministration, 2017–2027
Figure 72: Latin America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2027
Figure 73: Latin America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Country, 2017–2027
Figure 74: Varicella Zoster Infection Treatment Market Split By Drug Type (2017)
Figure 75: Varicella Zoster Infection Treatment Market Split By Route of Administration (2017)
Figure 76: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2017)
Figure 77: Varicella Zoster Infection Treatment Market Split By Country (2017)
Figure 78: Western Europe Varicella Zoster Infection Treatment Market Size Analysis, 2012–2016
Figure 79: Western Europe Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2017–2027
Figure 80: Germany Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 81: Germany Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 82: U.K. Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 83: U.K. Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 84: France Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 85: France Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 86: Italy Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 87: Italy Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 88: Spain Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 89: Spain Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 90: Rest of Western Europe Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 91: Rest of Western Europe Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 92: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 93: Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 94: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 95: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 96: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 97: Famciclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 98: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 99: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 100: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 101: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 102: Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 103: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 104: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 105: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 106: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 107: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 108: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 109: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 110: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 111: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 112: Western Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2017–2027
Figure 113: Western Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027
Figure 114: Western Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2027
Figure 115: Western Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By Country, 2017–2027
Figure 116: Varicella Zoster Infection Treatment Market Split By Drug Type (2017)
Figure 117: Varicella Zoster Infection Treatment Market Split By Route of Administration (2017)
Figure 118: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2017)
Figure 119: Varicella Zoster Infection Treatment Market Split By Country (2017)
Figure 120: Eastern Europe Varicella Zoster Infection Treatment Market Size Analysis, 2012–2016
Figure 121: Eastern Europe Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2017–2027
Figure 122: Russia Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 123: Russia Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 124: Poland Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 125: Poland Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 126: Rest of Eastern Europe Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 127: Rest of Eastern Europe Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 128: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 129:Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 130: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 131: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 132: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 133: Famciclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 134: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 135: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 136: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 137: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 138: Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 139: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 140: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 141: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 142: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 143: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 144: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 145: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 146: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 147: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 148: Eastern Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2017–2027
Figure 149: Eastern Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of
Administration, 2017–2027
Figure 150: Eastern Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By DistributionChannel, 2017–2027
Figure 151: Eastern Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By Country, 2017–2027
Figure 152: Varicella Zoster Infection Treatment Market Split By Drug Type (2017)
Figure 153: Varicella Zoster Infection Treatment Market Split By Route of Administration (2017)
Figure 154: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2017)
Figure 155: Varicella Zoster Infection Treatment Market Split By Country (2017)
Figure 156: APECJ Varicella Zoster Infection Treatment Market Size Analysis, 2012–2016
Figure 157: APECJ Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2017–2027
Figure 158: India Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 159: India Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 160: Australia & New Zealand Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 161: Australia & New Zealand Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 162: ASEAN Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 163: ASEAN Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 164: Rest of APEJ Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 165: Rest of APEJ Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 166: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 167: Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 168: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 169: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 170: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 171: Famciclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 172: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 173: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 174: Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 175: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 176: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 177: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 178: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 179: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 180: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 181: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 182: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 183: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 184: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 185: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 186: APECJ Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2017–2027
Figure 187: APECJ Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027
Figure 188: APECJ Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2027
Figure 189: APECJ Varicella Zoster Infection Treatment Market Attractiveness Analysis By Country, 2017–2027
Figure 190: Varicella Zoster Infection Treatment Market Split By Drug Type (2017)
Figure 191: Varicella Zoster Infection Treatment Market Split By Route of Administration(2017)
Figure 192: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2017)
Figure 193: China Varicella Zoster Infection Treatment Market Size Analysis, 2012–2016
Figure 194: China Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2017–2027
Figure 195: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 196: Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 197: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 198: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 199: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 200: Famciclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 201: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 202: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 204: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 205: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 206: Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 207: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 208: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 209: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 210: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 211: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 212: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 213: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 214: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 215: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 216: China Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2017–2027
Figure 217: China Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027
Figure 218: China Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel,2017–2027
Figure 219: Varicella Zoster Infection Treatment Market Split By Drug Type (2017)
Figure 220: Varicella Zoster Infection Treatment Market Split By Route of Administration(2017)
Figure 221: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2017)
Figure 222:Japan Varicella Zoster Infection Treatment Market Size Analysis, 2012–2016
Figure 223: Japan Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2017–2027
Figure 224: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 225: Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 226: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 227: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 228: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 229: Famciclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 230: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 231: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 232: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 233: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 234: Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 235: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 236: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 237: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 238: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 239: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 240: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 241: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 242: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 243: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 244: Japan Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2017–2027
Figure 245: Japan Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of Administration,2017–2027
Figure 246: Japan Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel,2017–2027
Figure 247: Varicella Zoster Infection Treatment Market Split By Drug Type (2017)
Figure 248: Varicella Zoster Infection Treatment Market Split By Route of Administration (2017)
Figure 249: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2017)
Figure 250: Varicella Zoster Infection Treatment Market Split By Country (2017)
Figure 251: MEA Varicella Zoster Infection Treatment Market Size Analysis, 2012–2016
Figure 252: MEA Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2017–2027
Figure 253: GCC Countries Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 254: GCC Countries Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 255: South Africa Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 256: South Africa Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 257: North Africa Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 258: North Africa Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 259: Rest of MEA Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 260: Rest of MEA Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 261: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 262: Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 263: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 264: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 265: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 266: Famciclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 267: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 268: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 269: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 270: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 271: Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 272: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 273: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 274: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 275: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 276: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 277: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 278: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 279: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012–2016
Figure 280: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027
Figure 281: MEA Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2017–2027
Figure 282: MEA Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027
Figure 283: MEA Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2027
Figure 284: MEA Varicella Zoster Infection Treatment Market Attractiveness Analysis By Country, 2017–2027
Figure 285: Global Varicella Zoster Infection Treatment Market Attractiveness Analysis By Region, 2017–2027
Figure 286: Global Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2017–2027
Figure 287: Global Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027
Figure 288: Global Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2027
Figure 289: Global Varicella Zoster Infection Treatment Market Value Analysis and Forecast, 2016–2027 (US$ Mn)
Figure 290: Global Varicella Zoster Infection Treatment Market Absolute $ Opportunity (US$ Mn), 2016–2027